Robert Summitt, MD
Urogynecology and Reconstructive Pelvic Surgery · Germantown, TNNPI 1376568709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,864 of the $2,580 with a category attached, or 72.2%. 22 manufacturers reported payments, led by Axonics, Inc. at 29.2% of the total. Reporting peaked in 2021 at $1,065 and has fallen 67.7% since, to $344 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in TN, where the typical reported total is $5,304.
Across 83 payments — averaging $31.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$753
- Astellas Pharma US Inc$414
- Caldera Medical, Inc$412
- Sumitomo Pharma America, Inc.$233
- AbbVie$125
- Boston Scientific$80
- plus $564 from 16 others
What the payments were for
- Travel & lodging$53821%
- Food & beverage$1,86472%
- Education$1797%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 9 | $753 |
| Astellas Pharma US Inc | 13 | $414 |
| Caldera Medical, Inc | 10 | $412 |
| Sumitomo Pharma America, Inc. | 13 | $233 |
| AbbVie | 7 | $125 |
| Boston Scientific | 3 | $80 |
| Urovant Sciences Inc | 5 | $73 |
| Mayne Pharma Commercial LLC | 4 | $72 |
| Hologic Sales And Service, LLC | 3 | $70 |
| Laborie Medical Technologies Corp. | 3 | $46 |
| Channel Medsystems, Inc. | 1 | $39 |
| Pfizer | 2 | $37 |
| Applied Medical Resources Corporation | 1 | $32 |
| Aspira Women's Health Inc | 1 | $30 |
| Monaghan Medical Corporation | 1 | $29 |
| Exeltis, USA Inc. | 1 | $24 |
| Provepharm Inc. | 1 | $23 |
| Coopersurgical, Inc. | 1 | $22 |
| Northgate Technologies, Inc. | 1 | $21 |
| Scynexis, Inc. | 1 | $17 |
| Optumhealth Care Solutions, LLC | 1 | $17 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$538
- Bulkamid$538
- Desara$120
How this compares
$2,580 in reported general payments places this provider in the 30th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Tennessee.
See all urogynecology and reconstructive pelvic surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 114 | $81,261 |
| GemtesaVibegron | 70 | $48,772 |
| Estradiol | 361 | $23,769 |
| PremarinEstrogens, Conjugated | 39 | $14,544 |
| Solifenacin Succinate | 230 | $12,349 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 224 | $7,186 |
| Trimethoprim | 61 | $4,240 |
| Trospium Chloride ErTrospium Chloride | 22 | $3,758 |
| Imipramine Hcl | 200 | $2,978 |
| Oxybutynin Chloride ErOxybutynin Chloride | 60 | $1,895 |
| Tolterodine Tartrate ErTolterodine Tartrate | 20 | $1,717 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 11 | $1,313 |
| Fosfomycin Tromethamine | 11 | $714 |
| Estradiol (Twice Weekly)Estradiol | 14 | $702 |
| Bethanechol Chloride | 14 | $662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $414 | $81,261114 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $233 | $48,77270 claims |
| PfizerPremarin | $37 | $14,54439 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Tennessee.
Other urogynecology and reconstructive pelvic surgery in Germantown
- Val VogtGermantown$6K
- Tara AllenNashville$100K
- Barry JarnaginFranklin$57K
- C BowlingKnoxville$52K
- Rena AzarSouth Pittsburg$23K
- Marcy AbelNashville$22K
- Roland HuffakerJohnson City$17K
- Henry OkaforChattanooga$13K
- Carson KaeserChattanooga$10K
- Jeffrey McQuearyBristol$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.